Conceptual
Browse Instruct Curate
Login

Pembrolizumab Treatment for Advanced Esophageal Cancer

The transcript for this video contains no spoken or captioned content beyond music and applause cues, so no theoretical content is available to extract from the source material itself. Based solely on the title, the subject concerns immune checkpoint inhibitor theory in oncology: the use of pembrolizumab, a PD-1 (programmed cell death protein 1) inhibitor, as a treatment for advanced esophageal cancer, within the domain of immuno-oncology and gastrointestinal malignancy pharmacotherapy.